BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32239692)

  • 1. Management of nail psoriasis by topical drug delivery: a pharmaceutical perspective.
    Thatai P; Khan AB
    Int J Dermatol; 2020 Aug; 59(8):915-925. PubMed ID: 32239692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1st meeting on topical drug delivery to the nail.
    Murdan S
    Expert Opin Drug Deliv; 2007 Jul; 4(4):453-5. PubMed ID: 17683257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into drug delivery across the nail plate barrier.
    Saner MV; Kulkarni AD; Pardeshi CV
    J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the nail permeability of topically applied drugs.
    Murdan S
    Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ungual and transungual drug delivery.
    Shivakumar HN; Juluri A; Desai BG; Murthy SN
    Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery to the nail following topical application.
    Murdan S
    Int J Pharm; 2002 Apr; 236(1-2):1-26. PubMed ID: 11891066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Patents on Permeation Enhancers for Drug Delivery Through Nails.
    Kreutz T; de Matos SP; Koester LS
    Recent Pat Drug Deliv Formul; 2019; 13(3):203-218. PubMed ID: 31663846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders.
    Brown M; Turner R; Wevrett SR
    Expert Opin Drug Deliv; 2018 Oct; 15(10):983-989. PubMed ID: 30173543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
    Murthy SN; Vaka SR; Sammeta SM; Nair AB
    J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery to the nail: therapeutic options and challenges for onychomycosis.
    Barot BS; Parejiya PB; Patel HK; Mehta DM; Shelat PK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(6):459-94. PubMed ID: 25271773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iontophoretic drug delivery across the nail.
    Delgado-Charro MB
    Expert Opin Drug Deliv; 2012 Jan; 9(1):91-103. PubMed ID: 22149385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iontophoresis to Overcome the Challenge of Nail Permeation: Considerations and Optimizations for Successful Ungual Drug Delivery.
    Chen K; Puri V; Michniak-Kohn B
    AAPS J; 2021 Jan; 23(1):25. PubMed ID: 33439400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transungual delivery: deliberations and creeds.
    Thatai P; Sapra B
    Int J Cosmet Sci; 2014 Oct; 36(5):398-411. PubMed ID: 24888698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routes of drug delivery into the nail apparatus: Implications for the efficacy of topical nail solutions in onychomycosis.
    Gupta AK; Simpson FC
    J Dermatolog Treat; 2016; 27(1):2-4. PubMed ID: 25983025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A focused review on laser- and energy-assisted drug delivery for nail disorders.
    Konisky H; Klinger R; Coe L; Jaller JA; Cohen JL; Kobets K
    Lasers Med Sci; 2024 Jan; 39(1):39. PubMed ID: 38240827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
    Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nail disorders in older people, and aspects of their pharmaceutical treatment.
    Murdan S
    Int J Pharm; 2016 Oct; 512(2):405-411. PubMed ID: 27180233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transungual drug delivery: current status.
    Elkeeb R; AliKhan A; Elkeeb L; Hui X; Maibach HI
    Int J Pharm; 2010 Jan; 384(1-2):1-8. PubMed ID: 19819318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.